Comments for CRXL - Stockpickr! Your Source for Stock Ideas

Comments for CRXL

Added By	Comments	Type	Date Added
Stockpickr Staff	"Johnson & Johnson (JNJ) has purchased 14.6 million shares of Dutch biotech company Crucell (CRXL) for 301.8 million euros ($441 million)." <a href="http://www.thestreet.com/story/10603994/1/jj-buys-18-stake-in-biotech-firm-crucell.html" target="_blank">Read more here.</a>	Love	September 28, 2009
barrons3	On the vaccine side, companies like GlaxoSmithKline, Baxter(BAX) and Crucell(CRXL) stand to benefit, he said.	Love	April 29, 2009
Dr Ed	OLD HOLDING	Love	October 16, 2008
Dr Ed	OLD HOLDING	Love	October 16, 2008
Dr Ed	OLD HOLDING	Love	October 16, 2008
flosz	Per.c6/STAR The manufacturing of biopharmaceuticals is subject to many changes, such as rising volume demands and more stringent safety requirements. These conditions challenge conventional manufacturing platforms, which have not or cannot adapt sufficiently to address these changes. Crucell’s PER.C6® technology has been designed to meet these demands. Crucell’s STAR® technology is useful for increasing production of recombinant antibodies and therapeutic proteins on mammalian cell lines.	Love	April 12, 2008
stockerblog	negative earnings	Love	June 23, 2007
pickr007	PER.C6 tech used by Sanofi in H5N1 vaccine development	Love	May 08, 2007
sarah z	PER.C6 tech used by Sanofi in H5N1 vaccine development	Love	May 03, 2007
wallisweaver	Good pipeline and technology	Love	April 27, 2007